NCT02213289 2021-04-08PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond ProgressionUniversity of ChicagoPhase 2 Completed80 enrolled 14 charts
NCT01253525 2014-06-18Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric AdenocarcinomasEli Lilly and CompanyPhase 1 Completed6 enrolled 18 charts